Singular Genomics Systems Inc (NAS:OMIC)
$ 0.348 0.0052 (1.52%) Market Cap: 25.78 Mil Enterprise Value: -51.80 Mil PE Ratio: 0 PB Ratio: 0.16 GF Score: 32/100

Q4 2022 Singular Genomics Systems Inc Earnings Call Transcript

Mar 02, 2023 / 09:30PM GMT
Release Date Price: $2.09 (+6.63%)
Operator

Greetings, and welcome to the Singular Genomics Systems, Inc. Fourth Quarter 2022 Earnings Conference Call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host, Mr. Philip Taylor. Sir, you may begin.

Philip Taylor
Gilmartin Group LLC - Associate

Thank you, operator. Presenting today are Singular Genomics' Founder and Chief Executive Officer, Drew Spaventa; and Chief Financial Officer, Dalen Meeter. Earlier today, Singular Genomics released financial results for the 3 months ended December 31, 2022. A copy of the press release is available on the company's website.

Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, March 2, 2023 only, and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations and other information related to our financial and operating results, plans and strategies. Actual results may differ materially from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot